Invesco Pharmaceuticals ETF
PJP
90 hedge funds and large institutions have $113M invested in Invesco Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 31 reducing their positions, and 13 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
6% more capital invested
Capital invested by funds: $107M → $113M (+$6.24M)
1.41% more ownership
Funds ownership: 14.23% → 15.64% (+1.4%)
9% less funds holding
Funds holding: 99 → 90 (-9)
29% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 31
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$14.3M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$1.37M |
| 3 |
VF
Virtu Financial
New York
|
+$638K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$390K |
| 5 |
Jane Street
New York
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atria Investments
Charlotte,
North Carolina
|
-$3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.38M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.27M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.34M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.05M |
PJP Hedge Fund Activity: Q3 2017 in Review
90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2017, worth a combined $113M — up 5.8% from $107M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PJP and 6 opened new positions — a net loss of 7 holders — while 31 trimmed existing stakes and 22 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $14.3M. The largest seller was Atria Investments, exiting entirely with an estimated $3M sold.
- 90 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2017, down from 99 in Q2 2017.
- Funds reported $113M of Invesco Pharmaceuticals ETF stock for Q3 2017, up 5.8% quarter-over-quarter.
- 6 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2017 and 13 closed out, a net change of -7 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2017 was Two Sigma Securities, an estimated $14.3M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2017 was Atria Investments, an estimated $3M sold.
Based on aggregated 13F filings for Q3 2017.